Abiopharma

New Form SCHEDULE 13D/A - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039388 <b>Size:</b> 5 KB

New Form N-PX - Nuveen S&P 500 Dynamic Overwrite Fund <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002619 <b>Size:</b> 3 MB

New Form SCHEDULE 13G - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039385 <b>Size:</b> 7 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer

New Form N-PX - NUVEEN REAL ESTATE INCOME FUND <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002617 <b>Size:</b> 245 KB

New Form SCHEDULE 13G - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039382 <b>Size:</b> 6 KB

New Form N-PX - Nuveen Real Asset Income & Growth Fund <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002616 <b>Size:</b> 1 MB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Changes in Interest of Substantial Shareholders

Change in holdings of interested parties/officers

Waiver: Waivers from compliance with certain rules of the SGXT-ST Listing Manual

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Changes in Interest of Substantial Shareholders

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Notification of BlackRock, Inc. in Respect of Becoming a Substantial Shareholder

New Form N-PX - Nuveen Quality Municipal Income Fund <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002615 <b>Size:</b> 13 KB

Duluth Holdings Inc. to Report Second Quarter 2026 Financial Results on September 3, 2026

New Form SCHEDULE 13D - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039379 <b>Size:</b> 9 KB